These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

863 related items for PubMed ID: 20373368

  • 1. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP.
    Hepatology; 2010 Apr; 51(4):1209-17. PubMed ID: 20373368
    [Abstract] [Full Text] [Related]

  • 2. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
    Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A, Dongiovanni P, Fargion S, Nobili V.
    Hepatology; 2010 Oct; 52(4):1274-80. PubMed ID: 20648474
    [Abstract] [Full Text] [Related]

  • 3. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.
    Valenti L, Rumi M, Galmozzi E, Aghemo A, Del Menico B, De Nicola S, Dongiovanni P, Maggioni M, Fracanzani AL, Rametta R, Colombo M, Fargion S.
    Hepatology; 2011 Mar; 53(3):791-9. PubMed ID: 21319195
    [Abstract] [Full Text] [Related]

  • 4. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
    Wang CW, Lin HY, Shin SJ, Yu ML, Lin ZY, Dai CY, Huang JF, Chen SC, Li SS, Chuang WL.
    Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282
    [Abstract] [Full Text] [Related]

  • 5. Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C.
    Yasui K, Kawaguchi T, Shima T, Mitsuyoshi H, Seki K, Sendo R, Mizuno M, Itoh Y, Matsuda F, Okanoue T.
    J Gastroenterol; 2015 Aug; 50(8):887-93. PubMed ID: 25543233
    [Abstract] [Full Text] [Related]

  • 6. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B.
    Viganò M, Valenti L, Lampertico P, Facchetti F, Motta BM, D'Ambrosio R, Romagnoli S, Dongiovanni P, Donati B, Fargion S, Colombo M.
    Hepatology; 2013 Oct; 58(4):1245-52. PubMed ID: 23564580
    [Abstract] [Full Text] [Related]

  • 7. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.
    Sookoian S, Pirola CJ.
    Hepatology; 2011 Jun; 53(6):1883-94. PubMed ID: 21381068
    [Abstract] [Full Text] [Related]

  • 8. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
    Valenti L, Maggioni P, Piperno A, Rametta R, Pelucchi S, Mariani R, Dongiovanni P, Fracanzani AL, Fargion S.
    World J Gastroenterol; 2012 Jun 14; 18(22):2813-20. PubMed ID: 22719190
    [Abstract] [Full Text] [Related]

  • 9. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
    Chen LZ, Xin YN, Geng N, Jiang M, Zhang DD, Xuan SY.
    World J Gastroenterol; 2015 Jan 21; 21(3):794-802. PubMed ID: 25624712
    [Abstract] [Full Text] [Related]

  • 10. LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease.
    Valenti L, Motta BM, Alisi A, Sartorelli R, Buonaiuto G, Dongiovanni P, Rametta R, Pelusi S, Fargion S, Nobili V.
    J Pediatr Gastroenterol Nutr; 2012 May 21; 54(5):588-93. PubMed ID: 22157924
    [Abstract] [Full Text] [Related]

  • 11. [Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease].
    Xu J, Xin YN, Lü WH, Lin ZH, Zhang DD, Zhang M, Dong QJ, Jiang XJ, Xuan SY.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug 21; 21(8):619-23. PubMed ID: 24119744
    [Abstract] [Full Text] [Related]

  • 12. PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes.
    Petit JM, Guiu B, Masson D, Duvillard L, Jooste V, Buffier P, Bouillet B, Brindisi MC, Robin I, Gambert P, Verges B, Cercueil JP, Hillon P.
    Liver Int; 2011 Oct 21; 31(9):1332-6. PubMed ID: 21745307
    [Abstract] [Full Text] [Related]

  • 13. The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls.
    Valenti L, Rametta R, Ruscica M, Dongiovanni P, Steffani L, Motta BM, Canavesi E, Fracanzani AL, Mozzi E, Roviaro G, Magni P, Fargion S.
    BMC Gastroenterol; 2012 Aug 16; 12():111. PubMed ID: 22898488
    [Abstract] [Full Text] [Related]

  • 14. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Tai CM, Huang CK, Tu HP, Hwang JC, Chang CY, Yu ML.
    Surg Obes Relat Dis; 2015 Aug 16; 11(4):888-94. PubMed ID: 25240529
    [Abstract] [Full Text] [Related]

  • 15. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
    Hotta K, Yoneda M, Hyogo H, Ochi H, Mizusawa S, Ueno T, Chayama K, Nakajima A, Nakao K, Sekine A.
    BMC Med Genet; 2010 Dec 22; 11():172. PubMed ID: 21176169
    [Abstract] [Full Text] [Related]

  • 16. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
    Manchiero C, Nunes AKDS, Magri MC, Dantas BP, Mazza CC, Barone AA, Tengan FM.
    BMC Infect Dis; 2017 Dec 19; 17(1):780. PubMed ID: 29258449
    [Abstract] [Full Text] [Related]

  • 17. Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis.
    Finkenstedt A, Auer C, Glodny B, Posch U, Steitzer H, Lanzer G, Pratschke J, Biebl M, Steurer M, Graziadei I, Vogel W, Zoller H.
    Clin Gastroenterol Hepatol; 2013 Dec 19; 11(12):1667-72. PubMed ID: 23872669
    [Abstract] [Full Text] [Related]

  • 18. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.
    Valenti L, Nobili V, Al-Serri A, Rametta R, Leathart JB, Zappa MA, Dongiovanni P, Fracanzani AL, Alterio A, Roviaro G, Daly AK, Fargion S, Day CP.
    J Hepatol; 2011 Dec 19; 55(6):1409-14. PubMed ID: 21777557
    [Abstract] [Full Text] [Related]

  • 19. Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea.
    Lee SS, Byoun YS, Jeong SH, Woo BH, Jang ES, Kim JW, Kim HY.
    Dig Dis Sci; 2014 Dec 19; 59(12):2967-74. PubMed ID: 25069572
    [Abstract] [Full Text] [Related]

  • 20. Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease.
    Liu WY, Zheng KI, Pan XY, Ma HL, Zhu PW, Wu XX, Rios RS, Targher G, Byrne CD, Wang XD, Chen YP, Zheng MH.
    J Gastroenterol Hepatol; 2020 Jun 19; 35(6):1057-1064. PubMed ID: 31677195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.